Dizon, Glenda D.
HRN: 10-65-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2026
MUPIROCIN 2%, 15G (TUBE)
07/25/2026
08/01/2026
TOPICAL
2%
OD
Infected Wound Bid Toe, R
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: